CORIENT CAPITAL PARTNERS, LLC Edwards Lifesciences Corporation Transaction History

CORIENT CAPITAL PARTNERS, LLC portfolio value:

$1.07M
portfolio value

CORIENT CAPITAL PARTNERS, LLC quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +3.82% 414 shares 39K $82.63 11.26K
Q2 2022 share Increase +10.15% 1K shares -127K $95.09 10.84K
Q1 2022 share Increase +7.15% 657 shares -32K $117.72 9.84K
Q4 2021 share Decrease -45.70% -7.73K shares -725K $130.68 9.19K
Q3 2021 share Decrease -10.21% -1.92K shares -37K $113.21 16.92K
Q2 2021 share Increase +21.74% 3.36K shares 657K $103.57 18.85K
Q1 2021 share Increase +120.50% 8.46K shares 655K $83.64 15.48K
Q4 2020 share Increase +3.20% 218 shares 98K $91.23 7.02K
Q3 2020 share Decrease -2.27% -158 shares 62K $79.82 6.80K
Q2 2020 share Increase +10.68% 672 shares 86K $69.11 6.96K
Q1 2020 share Decrease -10.77% -759 shares -154K $62.87 6.29K
Q4 2019 share Increase +4.86% 327 shares 57K $77.76 7.05K
Q3 2019 share Increase +30.59% 1.57K shares 175K $73.3 6.72K
Q2 2019 share Increase +7.38% 354 shares 11K $61.58 5.14K
Q1 2019 share Increase 0.00% 4.79K shares 306K $63.78 4.79K